(S)-N-[cyclopropyl-[1-(2-trimethylsilylethoxymethyl)benzimidazol-5-yl]methyl]-2-methylpropane-2-sulfinamide

C21H35N3O2SSi — CID 171777693

IUPAC(S)-N-[cyclopropyl-[1-(2-trimethylsilylethoxymethyl)benzimidazol-5-yl]methyl]-2-methylpropane-2-sulfinamide
SMILESCC(C)(C)[S@](=O)NC(c1ccc2c(c1)ncn2COCC[Si](C)(C)C)C1CC1
InChIInChI=1S/C21H35N3O2SSi/c1-21(2,3)27(25)23-20(16-7-8-16)17-9-10-19-18(13-17)22-14-24(19)15-26-11-12-28(4,5)6/h9-10,13-14,16,20,23H,7-8,11-12,15H2,1-6H3/t20?,27-/m0/s1
InChIKeyMHQAMZLUGQLIGH-OHMHCFLMSA-N
MW421.68 g/mol
LogP4.85
Rot. Bonds9

About (S)-N-[cyclopropyl-[1-(2-trimethylsilylethoxymethyl)benzimidazol-5-yl]methyl]-2-methylpropane-2-sulfinamide

(S)-N-[cyclopropyl-[1-(2-trimethylsilylethoxymethyl)benzimidazol-5-yl]methyl]-2-methylpropane-2-sulfinamide (PubChem CID 171777693) has the molecular formula C21H35N3O2SSi and a molecular weight of 421.68 g/mol. Its IUPAC name is (S)-N-[cyclopropyl-[1-(2-trimethylsilylethoxymethyl)benzimidazol-5-yl]methyl]-2-methylpropane-2-sulfinamide.

Molecular Properties

Compound Name(S)-N-[cyclopropyl-[1-(2-trimethylsilylethoxymethyl)benzimidazol-5-yl]methyl]-2-methylpropane-2-sulfinamide
PubChem CID171777693
Molecular FormulaC21H35N3O2SSi
Molecular Weight421.68 g/mol
Exact Mass421.22
IUPAC Name(S)-N-[cyclopropyl-[1-(2-trimethylsilylethoxymethyl)benzimidazol-5-yl]methyl]-2-methylpropane-2-sulfinamide
SMILESCC(C)(C)[S@](=O)NC(c1ccc2c(c1)ncn2COCC[Si](C)(C)C)C1CC1
InChIInChI=1S/C21H35N3O2SSi/c1-21(2,3)27(25)23-20(16-7-8-16)17-9-10-19-18(13-17)22-14-24(19)15-26-11-12-28(4,5)6/h9-10,13-14,16,20,23H,7-8,11-12,15H2,1-6H3/t20?,27-/m0/s1
InChIKeyMHQAMZLUGQLIGH-OHMHCFLMSA-N
XLogP4.85
TPSA56.15 Ų
H-Bond Donors1
H-Bond Acceptors4
Rotatable Bonds9
Heavy Atoms28
Complexity

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500421.68
LogP ≤ 54.85
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 104

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}, {'alert_name': 'heavy_metal', 'substructure': 'N/A'}

Analyze (S)-N-[cyclopropyl-[1-(2-trimethylsilylethoxymethyl)benzimidazol-5-yl]methyl]-2-methylpropane-2-sulfinamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of (S)-N-[cyclopropyl-[1-(2-trimethylsilylethoxymethyl)benzimidazol-5-yl]methyl]-2-methylpropane-2-sulfinamide?
The IUPAC name of (S)-N-[cyclopropyl-[1-(2-trimethylsilylethoxymethyl)benzimidazol-5-yl]methyl]-2-methylpropane-2-sulfinamide (CID 171777693) is (S)-N-[cyclopropyl-[1-(2-trimethylsilylethoxymethyl)benzimidazol-5-yl]methyl]-2-methylpropane-2-sulfinamide.
What is the SMILES notation for (S)-N-[cyclopropyl-[1-(2-trimethylsilylethoxymethyl)benzimidazol-5-yl]methyl]-2-methylpropane-2-sulfinamide?
The canonical SMILES for (S)-N-[cyclopropyl-[1-(2-trimethylsilylethoxymethyl)benzimidazol-5-yl]methyl]-2-methylpropane-2-sulfinamide is CC(C)(C)[S@](=O)NC(c1ccc2c(c1)ncn2COCC[Si](C)(C)C)C1CC1.
What is the InChIKey of (S)-N-[cyclopropyl-[1-(2-trimethylsilylethoxymethyl)benzimidazol-5-yl]methyl]-2-methylpropane-2-sulfinamide?
The InChIKey is MHQAMZLUGQLIGH-OHMHCFLMSA-N. The full InChI is InChI=1S/C21H35N3O2SSi/c1-21(2,3)27(25)23-20(16-7-8-16)17-9-10-19-18(13-17)22-14-24(19)15-26-11-12-28(4,5)6/h9-10,13-14,16,20,23H,7-8,11-12,15H2,1-6H3/t20?,27-/m0/s1.
What are the key properties of (S)-N-[cyclopropyl-[1-(2-trimethylsilylethoxymethyl)benzimidazol-5-yl]methyl]-2-methylpropane-2-sulfinamide?
(S)-N-[cyclopropyl-[1-(2-trimethylsilylethoxymethyl)benzimidazol-5-yl]methyl]-2-methylpropane-2-sulfinamide has a molecular weight of 421.68 g/mol, XLogP of 4.85, 9 rotatable bonds, 1 hydrogen bond donors, and 4 hydrogen bond acceptors.
Where does this data come from?
All data for (S)-N-[cyclopropyl-[1-(2-trimethylsilylethoxymethyl)benzimidazol-5-yl]methyl]-2-methylpropane-2-sulfinamide is sourced from PubChem (CID 171777693), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).